Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,390.00    -65.00 (-1.19%)
Bid:
5,410.00
Ask:
5,420.00
Spread: 10.00 (0.185%)
Market Cap: £3.92b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Trading Statement

18 Oct 2018 07:00

RNS Number : 4018E
Renishaw PLC
18 October 2018
Β 

Renishaw plc

Trading update

18th October 2018

Renishaw plc, the global high-precision metrology and healthcare technology group, publishes this trading update for the three months ended 30th September 2018. It contains unaudited information that covers the first quarter and the period since.

Β 

Trading activity

Β 

Continuing operations

First quarter2019

First quarter2018

Change

Metrology

Β£147.4m

Β£137.1m

+8%

Healthcare

Β£6.6m

Β£5.2m

+27%

Total revenue

Β£154.0m

Β£142.3m

+8%

Β 

Adjusted* profit before tax

Β£32.6m

Β£35.8m

-9%

Statutory profit before tax

Β£33.5m

Β£36.9m

-9%

Β 

Revenue from continuing operations for the first quarter of the current financial year was Β£154.0m, a growth of 8% over the Β£142.3m for the corresponding period last year. We experienced growth for the period at constant exchange rates of 7% with growth in all regions.

Β 

In our metrology business revenue amounted to Β£147.4m compared to Β£137.1m last year, with growth at constant exchange rates of 7%. Revenue in our healthcare business was Β£6.6m compared with Β£5.2m last year, a growth of 25% at constant exchange rates.

Β 

The Adjusted* profit before tax from continuing operations for the first quarter amounted to Β£32.6m compared with Β£35.8m last year and the statutory profit before tax amounted to Β£33.5m (2018: Β£36.9m).

Β 

Over recent years, we have invested in people and infrastructure to support growth opportunities and are now well placed to benefit from these investments. We anticipate the rate of investment in additional resources will reduce in the remainder of the current financial year as we continue to monitor the Group's cost base.

Β 

Financial positionΒ 

The Group balance sheet remains strong with net cash balances of Β£115.3m as at 30th September 2018Β compared to Β£103.8m at 30th June 2018.

Β 

Outlook

Despite the potential impacts of Brexit and economic uncertainties in Asia the Board remains confident in the future prospects of the Group and of growth in both revenue and profit in this financial year.

The results for the half year ending 31st December 2018 will be released on 31st January 2019.

Β 

Sir David McMurtry

William Lee

CBE, RDI, FRS, FREng, CEng, FIMechE

Chief Executive Officer

Executive Chairman

Β 

Β 

Β 

18th October 2018

Β 

Β 

Β 

Β 

Β 

Β 

Renishaw plc

Β 

Registered office

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number

1106260

LEI number

21380048ADXM6Z67CT18

Telephone number

01453 524524

Website

www.renishaw.com

Β 

Β 

Β 

Β 

* Adjusted profit before tax

Β 

Β 

The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IFRS9 'Financial Instruments', or the criteria set out in IAS39 'Financial Instruments: Recognition and Measurement' used in the prior year. The Board deems that the adjusted profit before tax better reflects the underlying performance of the Group. The following table reconciles statutory profit before tax to adjusted profit before tax:

Β 

Β 

Β 

Β 

Β 

Β 

Β£'m

Q1 2019

Β 

Q1 2018

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Adjusted profit before tax

32.6

Β 

35.8

Β 

Β 

Β 

Β 

Fair value gains/losses on financial instruments not eligible for hedge accounting

Β 

Β 

Β 

- reported in revenue

1.8

Β 

0.1

- reported in (losses)/gains from the fair value of financial instruments

(0.9)

Β 

1.0

Β 

Β 

Β 

Β 

Statutory profit before tax from continuing operations

33.5

Β 

36.9

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTEAKEXFLKPFFF
Date   Source Headline
16th May 20239:45 amRNSAGM Voting Results Update Statement
9th May 20233:39 pmRNSNotice of Investor Day
28th Apr 20237:00 amRNSTrading Statement
2nd Feb 20237:00 amRNSHalf-year Report
24th Jan 20233:11 pmRNSNotice of Half-year Results
30th Nov 20224:38 pmRNSResult of AGM
31st Oct 20221:00 pmRNSNotice of AGM
28th Oct 20229:15 amRNSDirector/PDMR Shareholding
27th Oct 20227:00 amRNSTrading Statement
30th Sep 20227:00 amRNSAnnual Financial Report
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSFinal Results
6th Sep 20221:00 pmRNSNotice of Results
1st Jul 202212:31 pmRNSDirector Declaration
16th May 20225:56 pmRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSAGM Voting Results Update Statement
10th May 20227:00 amRNSTrading Statement
12th Apr 202211:44 amRNSNotice of Investor Day
12th Apr 202210:58 amRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSDirectorate Change
18th Mar 20222:08 pmRNSHolding(s) in Company
14th Mar 20225:58 pmRNSDirector/PDMR Shareholding
1st Mar 20224:23 pmRNSDirectorate Change
3rd Feb 20227:00 amRNSHalf-year Report
17th Jan 20221:00 pmRNSNotice of Half-year Results
20th Dec 20214:05 pmRNSDirectorate Change
24th Nov 20213:57 pmRNSResult of AGM
29th Oct 20218:00 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSAnnual Financial Report
21st Oct 202111:50 amRNSFinal Results Replacement
21st Oct 20217:00 amRNSFinal Results
21st Oct 20217:00 amRNSTrading Statement
27th Sep 202110:52 amRNSFinal Results Revised Date and Trading Update
17th Sep 202110:35 amRNSNotice of Results
31st Aug 202112:31 pmRNSHolding(s) in Company
3rd Aug 20213:05 pmRNSDirector/PDMR Shareholding
8th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
8th Jul 20217:00 amRNSForm 8.3
7th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
7th Jul 20213:13 pmRNSForm 8.3 - Renishaw plc
7th Jul 20212:26 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
7th Jul 202111:48 amRNSForm 8.5 (EPT/NON-RI) - Renishaw plc
7th Jul 202111:14 amRNSForm 8.5 (EPT/RI) - Renishaw Plc
7th Jul 20217:00 amRNSUpdate on Formal Sale Process & Current Trading
6th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
6th Jul 20213:09 pmRNSForm 8.3 - Renishaw plc
6th Jul 20212:38 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:13 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:05 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
6th Jul 202111:36 amRNSForm 8.5 (EPT/RI) - Renishaw Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.